Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.
about
HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaquesErythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.Change in erythropoietin pharmacokinetics following hematopoietic transplantation.Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugsThe pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patientsA biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration.Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trialHigh-dose erythropoietin in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized controlled trials.The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.Epoetin beta for the treatment of chemotherapy-induced anemia: an update.Human erythropoietin dimers with markedly enhanced in vivo activity.Epoetin beta in oncology: examining the current evidence.Erythropoietin: from bench to bedside.Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development.Iron and anemia in human biology: a review of mechanisms.Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.Probing protease sensitivity of recombinant human erythropoietin reveals α3-α4 inter-helical loop as a stability determinant.Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).Erythropoietin: physiologic basis for clinical applications.Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited.Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheep.Erythropoietin production rate in phlebotomy-induced acute anemia.
P2860
Q24684076-22B56011-A216-42D9-B8D1-AB29FAE3792CQ30480727-4F725881-1B11-470A-8F5F-2CC64987272FQ33892534-F0A9896F-B90F-4708-99C3-29657FD61163Q34011214-880C86BA-E47A-434A-808C-EB69B4D909D3Q34403335-C3228BD5-642C-4EE7-87B3-A03C7F07483AQ34766672-30BB325D-BE0E-4552-BB7E-D8B84996B48DQ34800472-D837BA25-C126-498A-BA1C-0913F2C8C063Q35008662-4ED61F21-2DB8-4929-8393-8558D544F1ECQ35013346-6BD8C2FC-34A9-46ED-B667-ACF38F3F15E1Q35168681-6CDC34C1-DF1A-4949-B708-C525A33BDECFQ35799107-A03D578D-45F4-411F-84D5-7046993275EFQ36429666-C58979B4-297B-4257-9EC2-C1B2F0C52EF0Q36647464-112C3C3D-BF6E-479D-A516-7E3866438ED7Q36767393-203453DF-C02E-4FFD-9423-BF732C338AEBQ37117678-F6503814-1489-4B97-800C-68E61D2C0E57Q38126361-801C38A6-EFBF-49B6-91DA-17453D89E2DBQ38848944-875014CD-AA64-4012-BD64-A057FF499E97Q40351752-F541B4A9-B48D-49BB-8384-912C25B055BFQ40784296-A9E4A143-3E7B-4E30-BF83-EDF2AE496983Q45913481-0DA574E9-5AC2-433A-9DA0-E6142A6821C5Q50788864-57D3B838-16D3-40F8-9754-81D00E2630ABQ51934054-FC646537-6FD1-4035-9C4D-D5CD42215ED3Q51984793-9C988B29-CCFC-4A53-90CD-AB5597523693
P2860
Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@en
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@nl
type
label
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@en
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@nl
prefLabel
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@en
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@nl
P2093
P356
P1476
Pharmacokinetics and erythropo ...... erythropoietin in healthy men.
@en
P2093
Bjornsson TD
Flaharty KK
Vlasses PH
P304
P356
10.1038/CLPT.1990.76
P407
P577
1990-05-01T00:00:00Z